Source: StreetInsider

Press Release: Innovent Biologics : Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363PD-1/IL-2-biasand Other Novel Drug Candidates at the 2025 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU,China, April 23, 2025 /PRNewswire/ -- Innovent Biologics,...

Read full article »
Innovent Biologics's Competitors | Innovent Biologics's News | Innovent Biologics's Financials
Stay up-to-date with the latest news on Innovent Biologics
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Michael Yu's photo - Chairman & CEO of Innovent Biologics

Chairman & CEO

Michael Yu

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Innovent Biologics